US Stock MarketDetailed Quotes
TTOO T2 Biosystems
- 0.4100
- +0.0650+18.84%
Close Dec 26 16:00 ET
- 0.4200
- +0.0100+2.44%
Post 16:07 ET
8.63MMarket Cap-13.67P/E (TTM)
0.4400High0.3500Low1.72MVolume0.3673Open0.3450Pre Close691.10KTurnover21.62%Turnover RatioLossP/E (Static)21.04MShares6.950052wk High-0.74P/B3.26MFloat Cap0.310052wk Low--Dividend TTM7.95MShs Float122500.0000Historical High--Div YieldTTM26.09%Amplitude0.3100Historical Low0.4020Avg Price1Lot Size
Heat List
US
Overall
Symbol
Price
% Chg
No Data
T2 Biosystems Stock Forum
1. NFA
2. Do not open position without chart confirmation, indicators, momentum.
3. Check current shorts availability on FINTEL.io
4. Scale out and secure profits
5. Always remember shorts include dark pools.
6. Most importantly, don’t blame for your losses. I already give watchlist and stock education. The ball is on you.
7. I DO NOT give buy or sell advice
8. COH (cash on hand); AH (after hours): RTH (regular trading hours)
$Currenc Group (CURR.US)$ Despac Sk...
sepsis tests
Benzinga· 5 mins ago
The multiple instrument sale demonstrates commercial expansion to enable increased utilization of the T2Bacteria Panel, the T2Candida Panel, and the T2Resistance Panel. The target hospitals for the new instruments include:
Selling a second T2Dx Instrument to a major reference hospital to expand "same store" sales;Selling the first T2Dx Instrument to...
T2 Biosystems Achieves Key Milestone with 250,000th Novel Sepsis Test Shipped Globally
Tuesday, 17th December at 9:00 am
LEXINGTON, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it has surpassed the shipment of 250,000 sepsis tests, marking a significant milestone that underscores the growing customer adoption of the Company...
$Biomea Fusion (BMEA.US)$ Covalent III Trial regarding Type 2 Diabetes mellitus out tomorrow 8AM ET. SI 44.16%. COH $62.4M good for 6.2 months
$Sidus Space (SIDU.US)$ Satellite launch Friday. May continue until launch. Low float. 0 shares LTB.COH $4.8M good for 4.2 months✅
$Maison Solutions (MSS.US)$ PR AH 12/...
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement With Vizient, Inc.
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.
Monday, 16th December at 9:00 am
LEXINGTON, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that its multi-year capital equipment supplier agreement with Vizient, Inc., the largest member-driven health care performance improveme...
No comment yet